Michael S. Cuffe insider trades: HCA Healthcare (HCA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Michael reports to the SEC
Open-market buys and sales
42 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 3, 2026 | HCA | ↓ Sell | 1,500 | $498.09 | $747K | Direct | Feb 5, 2026 (2d) |
| Sep 8, 2025 | HCA | ↓ Sell | 3,836 | $418.84 | $1.6M | Direct | Sep 8, 2025 (0d) |
| Sep 12, 2024 | HCA | ↓ Sell | 8,358 | $385.42 | $3.2M | Direct | Sep 12, 2024 (0d) |
| May 9, 2024 | HCA | ↓ Sell | 6,311 | $316.88 | $2.0M | Direct | May 13, 2024 (4d) |
| May 6, 2024 | HCA | ↓ Sell | 1,600 | $309.00 | $494K | Direct | May 8, 2024 (2d) |
| Jan 31, 2024 | HCA | ↓ Sell | 3,200 | $306.79 | $982K | Direct | Feb 2, 2024 (2d) |
| Apr 28, 2023 | HCA | ↓ Sell | 12,556 | $284.44 | $3.6M | Direct | May 2, 2023 (4d) |
| Feb 1, 2023 | HCA | ↓ Sell | 4,000 | $257.11 | $1.0M | Direct | Feb 1, 2023 (0d) |
| Aug 3, 2021 | HCA | ↓ Sell | 2,500 | $251.91 | $630K | Direct | Aug 5, 2021 (2d) |
| Apr 29, 2021 | HCA | ↓ Sell | 18,664 | $201.53 | $3.8M | Direct | May 3, 2021 (4d) |
| Feb 5, 2021 | HCA | ↓ Sell | 21,292 | $174.42 | $3.7M | Direct | Feb 5, 2021 (0d) |
| Feb 5, 2020 | HCA | ↓ Sell | 6,459 | $150.00 | $969K | Direct | Feb 7, 2020 (2d) |
| Dec 23, 2019 | HCA | ↓ Sell | 5,891 | $147.04 | $866K | Direct | Dec 23, 2019 (0d) |
| Nov 9, 2018 | HCA | ↓ Sell | 4,943 | $141.90 | $701K | Direct | Nov 9, 2018 (0d) |
| Nov 2, 2018 | HCA | ↓ Sell | 5,196 | $136.52 | $709K | Direct | Nov 2, 2018 (0d) |
| Jul 30, 2018 | HCA | ↓ Sell | 5,313 | $125.26 | $665K | Direct | Jul 30, 2018 (0d) |
| Feb 9, 2018 | HCA | ↓ Sell | 8,335 | $97.26 | $811K | Direct | Feb 9, 2018 (0d) |
| Dec 15, 2017 | HCA | ↓ Sell | 2,400 | $86.63 | $208K | Direct | Dec 19, 2017 (4d) |
| Nov 22, 2017 | HCA | ↓ Sell | 2,150 | $78.00 | $168K | Direct | Nov 27, 2017 (5d) |
| Oct 17, 2017 | HCA | ↓ Sell | 2,150 | $78.00 | $168K | Direct | Oct 19, 2017 (2d) |
| Sep 15, 2017 | HCA | ↓ Sell | 2,150 | $79.87 | $172K | Direct | Sep 19, 2017 (4d) |
| Aug 15, 2017 | HCA | ↓ Sell | 2,150 | $79.88 | $172K | Direct | Aug 17, 2017 (2d) |
| Jul 17, 2017 | HCA | ↓ Sell | 2,150 | $86.44 | $186K | Direct | Jul 19, 2017 (2d) |
| Jun 15, 2017 | HCA | ↓ Sell | 2,150 | $84.86 | $182K | Direct | Jun 19, 2017 (4d) |
| May 15, 2017 | HCA | ↓ Sell | 2,150 | $84.52 | $182K | Direct | May 17, 2017 (2d) |
| Apr 17, 2017 | HCA | ↓ Sell | 2,150 | $85.00 | $183K | Direct | Apr 19, 2017 (2d) |
| Mar 15, 2017 | HCA | ↓ Sell | 2,150 | $84.10 | $181K | Direct | Mar 17, 2017 (2d) |
| Feb 15, 2017 | HCA | ↓ Sell | 2,150 | $83.75 | $180K | Direct | Feb 17, 2017 (2d) |
| Jan 17, 2017 | HCA | ↓ Sell | 2,150 | $80.00 | $172K | Direct | Jan 19, 2017 (2d) |
| Jan 9, 2017 | HCA | ↓ Sell | 4,300 | $78.00 | $335K | Direct | Jan 11, 2017 (2d) |
| Oct 28, 2016 | HCA | ↓ Sell | 2,150 | $79.41 | $171K | Direct | Nov 1, 2016 (4d) |
| May 24, 2016 | HCA | ↓ Sell | 2,575 | $76.20 | $196K | Direct | May 26, 2016 (2d) |
| Apr 25, 2016 | HCA | ↓ Sell | 2,575 | $80.73 | $208K | Direct | Apr 27, 2016 (2d) |
| Mar 24, 2016 | HCA | ↓ Sell | 2,575 | $76.19 | $196K | Direct | Mar 28, 2016 (4d) |
| Feb 24, 2016 | HCA | ↓ Sell | 2,575 | $70.00 | $180K | Direct | Feb 26, 2016 (2d) |
| Jan 28, 2016 | HCA | ↓ Sell | 5,150 | $70.00 | $361K | Direct | Feb 1, 2016 (4d) |
| Dec 1, 2015 | HCA | ↓ Sell | 2,575 | $70.00 | $180K | Direct | Dec 3, 2015 (2d) |
| Oct 26, 2015 | HCA | ↓ Sell | 2,575 | $70.00 | $180K | Direct | Oct 28, 2015 (2d) |
| Sep 24, 2015 | HCA | ↓ Sell | 2,575 | $83.42 | $215K | Direct | Sep 25, 2015 (1d) |
| Aug 24, 2015 | HCA | ↓ Sell | 2,575 | $82.32 | $212K | Direct | Aug 26, 2015 (2d) |
| May 18, 2015 | HCA | ↓ Sell | 5,000 | $80.72 | $404K | Direct | May 20, 2015 (2d) |
| Feb 19, 2015 | HCA | ↓ Sell | 6,500 | $69.81 | $454K | Direct | Feb 23, 2015 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other HCA insiders
Open-market trades in the last 12 months
About Michael S. Cuffe's insider trades
Michael S. Cuffe is EVP and Chief Clinical Officer at HCA Healthcare (HCA). Since Feb 19, 2015, Michael has reported no open-market purchases and 42 sales worth $31.9M on SEC Form 4. In the last 12 months: 1 sale ($747K).
Their filings also include option exercises (43 filings), shares withheld for taxes (29 filings), grants and awards (25 filings), gifts (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HCA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.